Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines

Variable response to drug treatment and withdrawal

Dominic E Cosgrove, G. Stanley Cox

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The effect of butyrate (Btr) and 5-azacytidine (azaC) on genomic DNA methylation was examined in a variety of human tumor cell lines. Butyrate treatment differentially affected 5-methylcytosine (m5C) content in a cell type-specific manner. For example, incubation of CBT cells (glioblastoma multiforme) for 48 h in medium containing 2 mM Btr resulted in the hypomethylation of their DNA; after removal of the drug, the m5C content was rapidly (24 h) restored to its original level. In contrast, when HeLa cells (cervical carcinoma) were cultured for 48 h in 3 mM Btr, their genomic DNA became more extensively methylated relative to the untreated control, and the hypermethylated state was maintained for long periods in culture. Treatment of HeLa cell lines with azaC resulted in extensive demethylation of their DNA. Following removal of the drug, the DNA was rapidly remethylated to levels equal to or greater than those of the untreated cells. The hypermethylated state has remained stable for over 180 generations. Together, the data suggest that cells respond rapidly to alter drug-induced reductions in the m5C content of their DNA, and this response can subsequently result in overmethylation. In contrast, when drug-induced hypermethylation of genomic DNA occurs, it may persist for many cell generations.

Original languageEnglish (US)
Pages (from-to)80-86
Number of pages7
JournalBBA - Gene Structure and Expression
Volume1087
Issue number1
DOIs
StatePublished - Sep 10 1990

Fingerprint

Drug therapy
Azacitidine
Butyric Acid
DNA Methylation
Tumor Cell Line
Tumors
Butyrates
Cells
DNA
Pharmaceutical Preparations
HeLa Cells
5-Methylcytosine
Glioblastoma
Cell culture
Carcinoma
Cell Line

Keywords

  • (Human)
  • 5-Azacytidine
  • DNA methylation
  • Sodium butyrate
  • Tumor cell line
  • genomic DNA

ASJC Scopus subject areas

  • Structural Biology
  • Biophysics
  • Biochemistry
  • Genetics

Cite this

@article{a9fd374d8c60496cbd45aa97d5e97463,
title = "Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines: Variable response to drug treatment and withdrawal",
abstract = "The effect of butyrate (Btr) and 5-azacytidine (azaC) on genomic DNA methylation was examined in a variety of human tumor cell lines. Butyrate treatment differentially affected 5-methylcytosine (m5C) content in a cell type-specific manner. For example, incubation of CBT cells (glioblastoma multiforme) for 48 h in medium containing 2 mM Btr resulted in the hypomethylation of their DNA; after removal of the drug, the m5C content was rapidly (24 h) restored to its original level. In contrast, when HeLa cells (cervical carcinoma) were cultured for 48 h in 3 mM Btr, their genomic DNA became more extensively methylated relative to the untreated control, and the hypermethylated state was maintained for long periods in culture. Treatment of HeLa cell lines with azaC resulted in extensive demethylation of their DNA. Following removal of the drug, the DNA was rapidly remethylated to levels equal to or greater than those of the untreated cells. The hypermethylated state has remained stable for over 180 generations. Together, the data suggest that cells respond rapidly to alter drug-induced reductions in the m5C content of their DNA, and this response can subsequently result in overmethylation. In contrast, when drug-induced hypermethylation of genomic DNA occurs, it may persist for many cell generations.",
keywords = "(Human), 5-Azacytidine, DNA methylation, Sodium butyrate, Tumor cell line, genomic DNA",
author = "Cosgrove, {Dominic E} and Cox, {G. Stanley}",
year = "1990",
month = "9",
day = "10",
doi = "10.1016/0167-4781(90)90124-K",
language = "English (US)",
volume = "1087",
pages = "80--86",
journal = "Biochimica et Biophysica Acta - Gene Structure and Expression",
issn = "0167-4781",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Effects of sodium butyrate and 5-azacytidine on DNA methylation in human tumor cell lines

T2 - Variable response to drug treatment and withdrawal

AU - Cosgrove, Dominic E

AU - Cox, G. Stanley

PY - 1990/9/10

Y1 - 1990/9/10

N2 - The effect of butyrate (Btr) and 5-azacytidine (azaC) on genomic DNA methylation was examined in a variety of human tumor cell lines. Butyrate treatment differentially affected 5-methylcytosine (m5C) content in a cell type-specific manner. For example, incubation of CBT cells (glioblastoma multiforme) for 48 h in medium containing 2 mM Btr resulted in the hypomethylation of their DNA; after removal of the drug, the m5C content was rapidly (24 h) restored to its original level. In contrast, when HeLa cells (cervical carcinoma) were cultured for 48 h in 3 mM Btr, their genomic DNA became more extensively methylated relative to the untreated control, and the hypermethylated state was maintained for long periods in culture. Treatment of HeLa cell lines with azaC resulted in extensive demethylation of their DNA. Following removal of the drug, the DNA was rapidly remethylated to levels equal to or greater than those of the untreated cells. The hypermethylated state has remained stable for over 180 generations. Together, the data suggest that cells respond rapidly to alter drug-induced reductions in the m5C content of their DNA, and this response can subsequently result in overmethylation. In contrast, when drug-induced hypermethylation of genomic DNA occurs, it may persist for many cell generations.

AB - The effect of butyrate (Btr) and 5-azacytidine (azaC) on genomic DNA methylation was examined in a variety of human tumor cell lines. Butyrate treatment differentially affected 5-methylcytosine (m5C) content in a cell type-specific manner. For example, incubation of CBT cells (glioblastoma multiforme) for 48 h in medium containing 2 mM Btr resulted in the hypomethylation of their DNA; after removal of the drug, the m5C content was rapidly (24 h) restored to its original level. In contrast, when HeLa cells (cervical carcinoma) were cultured for 48 h in 3 mM Btr, their genomic DNA became more extensively methylated relative to the untreated control, and the hypermethylated state was maintained for long periods in culture. Treatment of HeLa cell lines with azaC resulted in extensive demethylation of their DNA. Following removal of the drug, the DNA was rapidly remethylated to levels equal to or greater than those of the untreated cells. The hypermethylated state has remained stable for over 180 generations. Together, the data suggest that cells respond rapidly to alter drug-induced reductions in the m5C content of their DNA, and this response can subsequently result in overmethylation. In contrast, when drug-induced hypermethylation of genomic DNA occurs, it may persist for many cell generations.

KW - (Human)

KW - 5-Azacytidine

KW - DNA methylation

KW - Sodium butyrate

KW - Tumor cell line

KW - genomic DNA

UR - http://www.scopus.com/inward/record.url?scp=0025145509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025145509&partnerID=8YFLogxK

U2 - 10.1016/0167-4781(90)90124-K

DO - 10.1016/0167-4781(90)90124-K

M3 - Article

VL - 1087

SP - 80

EP - 86

JO - Biochimica et Biophysica Acta - Gene Structure and Expression

JF - Biochimica et Biophysica Acta - Gene Structure and Expression

SN - 0167-4781

IS - 1

ER -